NewslettersDermal Cell News Saracatinib Inhibits Necroptosis and Ameliorates Psoriatic Inflammation by Targeting MLKL By Laurisa Dohm - February 12, 2024 0 In an imiquimod-induced psoriasis mouse model, saracatinib effectively blocked mixed lineage kinase domain-like protein (MLKL) phosphorylation and inflammatory responses in vivo. [Cell Death & Disease] Full Article